Spectrum Pharmaceuticals Stock Price To Earnings To Growth
| SPPIDelisted Stock | USD 1.03 0.00 0.00% |
Spectrum Pharmaceuticals fundamentals help investors to digest information that contributes to Spectrum Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Spectrum Stock. The fundamental analysis module provides a way to measure Spectrum Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Spectrum Pharmaceuticals stock.
Spectrum |
Spectrum Pharmaceuticals Company Price To Earnings To Growth Analysis
Spectrum Pharmaceuticals' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Spectrum Pharmaceuticals has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Spectrum Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Spectrum Pharmaceuticals' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Spectrum Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Spectrum Pharmaceuticals by comparing valuation metrics of similar companies.Spectrum Pharmaceuticals is currently under evaluation in price to earnings to growth category among related companies.
Spectrum Fundamentals
| Return On Equity | -1.65 | |||
| Return On Asset | -0.38 | |||
| Profit Margin | (2.52) % | |||
| Operating Margin | (2.47) % | |||
| Current Valuation | 185.27 M | |||
| Shares Outstanding | 205.25 M | |||
| Shares Owned By Insiders | 11.00 % | |||
| Shares Owned By Institutions | 22.93 % | |||
| Number Of Shares Shorted | 3.33 M | |||
| Price To Earning | (19.44) X | |||
| Price To Book | 2.40 X | |||
| Revenue | 10.11 M | |||
| Gross Profit | 8.32 M | |||
| EBITDA | (77.06 M) | |||
| Net Income | (75.4 M) | |||
| Cash And Equivalents | 67.96 M | |||
| Cash Per Share | 0.37 X | |||
| Total Debt | 29.43 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 1.79 X | |||
| Book Value Per Share | 0.13 X | |||
| Cash Flow From Operations | (96.99 M) | |||
| Short Ratio | 3.74 X | |||
| Earnings Per Share | (0.36) X | |||
| Target Price | 1.26 | |||
| Number Of Employees | 86 | |||
| Beta | 2.14 | |||
| Market Capitalization | 211.4 M | |||
| Total Asset | 103.34 M | |||
| Retained Earnings | (1.12 B) | |||
| Working Capital | 58.33 M | |||
| Current Asset | 2.57 M | |||
| Current Liabilities | 2.52 M | |||
| Z Score | -12.54 | |||
| Net Asset | 103.34 M |
About Spectrum Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Spectrum Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spectrum Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spectrum Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Spectrum Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Spectrum Pharmaceuticals' short interest history, or implied volatility extrapolated from Spectrum Pharmaceuticals options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Spectrum Stock
If you are still planning to invest in Spectrum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spectrum Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |